Form 4: Viatris Inc. Director Harry Korman Reports Stock Transactions
SEC Form 4
Director Harry Korman reports acquisition and disposal of Viatris Inc. common stock and derivative securities due to vesting of restricted stock units and dividend equivalent units.
Summary
- On March 3, 2024, Harry Korman, a director of Viatris Inc., reported transactions involving the company's common stock.
- Korman acquired 17,970 shares of common stock through the vesting of restricted stock units (RSUs) at a price of $0.00.
- He also acquired 885 shares due to the settlement of dividend equivalent units (DEUs).
- Following these transactions, Korman directly owns 89,806 shares of Viatris Inc. common stock.
- On March 4, 2024, Korman was granted 18,204 restricted stock units that will vest on March 4, 2025.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing reflects routine transactions related to executive compensation. There are no indications of unusual or concerning activity.
Positives
- The vesting of RSUs and DEUs indicates that the director is receiving compensation tied to the company's performance.
Future Outlook
The director will receive shares of Viatris Inc. common stock upon the vesting of the 18,204 RSUs on March 4, 2025.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates standard compensation practices using RSUs and dividend equivalents.
Comparison to Industry Standards
- RSUs are a common form of executive compensation in the pharmaceutical industry, aligning management's interests with those of shareholders.
- Companies like Pfizer, Merck, and AbbVie also utilize RSUs as part of their compensation packages for directors and executives.
- The vesting schedules and terms of these RSUs are generally comparable to industry standards.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they represent a small change in the ownership structure of the company.
- Employees may view the vesting of RSUs as a positive sign of the company's commitment to its executives.
Key Dates
| Date | Description |
|---|---|
| 03/03/2023 | Date of original grant of RSUs that vested on March 3, 2024. |
| 03/03/2024 | Date of RSU vesting and dividend equivalent unit settlement. |
| 03/04/2024 | Date of grant of new RSUs that will vest on March 4, 2025. |
| 03/05/2024 | Date of signature on the Form 4 filing. |
| 03/04/2025 | Vesting date for the new RSUs granted on March 4, 2024. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.